Patents by Inventor James M. Koert

James M. Koert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4116769
    Abstract: Bioconversion of the antibiotic steffimycinone to the antibiotic steffimycinol. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes. Steffimycinol is converted to 7-deoxysteffimycinol by a microaerophilic Aeromonas hydrophila fermentation. 7-Deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, these antibiotics can be used to inhibit the growth of the above microorganisms in various environments.
    Type: Grant
    Filed: November 16, 1977
    Date of Patent: September 26, 1978
    Assignee: The Upjohn Company
    Inventors: Vincent P. Marshall, David W. Elrod, James M. Koert, Elizabeth A. Reisender, Paul F. Wiley
  • Patent number: 4106994
    Abstract: Bioconversion of the antibiotic steffimycinone to the antibiotic steffimycinol. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes. Steffimycinol is converted to 7-deoxysteffimycinol by a microaerophilic Aeromonas hydrophila fermentation. 7-Deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, these antibiotics can be used to inhibit the growth of the above microorganisms in various environments.
    Type: Grant
    Filed: November 16, 1977
    Date of Patent: August 15, 1978
    Assignee: The Upjohn Company
    Inventors: Vincent P. Marshall, David W. Elrod, James M. Koert, Elizabeth A. Reisender, Paul F. Wiley
  • Patent number: 4089872
    Abstract: Antibiotics steffimycinol and 7-deoxysteffimycinol produced by reduction of the antibiotic steffimycinone. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes; 7-deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, these antibiotics can be used to inhibit the growth of the above microorganisms in various environments.
    Type: Grant
    Filed: March 9, 1977
    Date of Patent: May 16, 1978
    Assignee: The Upjohn Company
    Inventors: James M. Koert, Paul F. Wiley
  • Patent number: 4077844
    Abstract: Bioconversion of the antibiotic steffimycinone to the antibiotic steffimycinol. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes. Steffimycinol is converted to 7-deoxysteffimycinol by a microaerophilic Aeromonas hydrophila fermentation. 7-Deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, there antibiotics can be used to inhibit the growth of the above microorganisms in various environments.
    Type: Grant
    Filed: March 30, 1977
    Date of Patent: March 7, 1978
    Assignee: The Upjohn Company
    Inventors: Vincent P. Marshall, David W. Elrod, James M. Koert, Elizabeth A. Reisender, Paul F. Wiley